<p>宾夕法尼亚州韦恩 --（商业资讯）-- 泰利福公司（NYSE: TFX）今天宣布，其董事会宣告每股普通股派发季度现金股息三十四美分（$0.34）。该股息将于 2026 年 6 月 30 日支付给截至 2026 年 5 月 25 日营业结束时的股东。</p>
<p><strong>关于泰利福公司</strong></p>
<p>作为全球医疗技术的提供者，泰利福的使命是改善人们的健康和生活质量。通过我们成为医疗保健最值得信赖的合作伙伴的愿景，我们提供多样化的产品组合，涵盖麻醉、急救医学、介入心脏病学和放射学、外科、血管通路和泌尿学等治疗领域。我们相信，优秀人才的潜力、以使命驱动的创新和世界级产品能够塑造医疗保健的未来方向。</p>
<p>泰利福是 Arrow™、Barrigel™、Deknatel™、LMA™、Pilling™、QuikClot™ Rüsch™、UroLift™和 Weck™的家园——这些受信赖的品牌因共同的使命而团结在一起。</p>
<p>在泰利福，我们正在赋能医疗保健的未来。欲了解更多信息，请访问 teleflex.com。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA1MTUxMzg1MDJyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA1MTUxMzg1MDJyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260515138502/en/</p>
<p>泰利福</p>
<p>劳伦斯·凯施</p>
<p>投资者关系与战略发展副总裁</p>
<p>investor.relations@teleflex.com</p>
<p>610-948-2836</p>
<p>来源：泰利福公司</p>

泰利福

<p>泰利福公司（NYSE: TFX）宣布将于 2026 年 6 月 30 日向截至 2026 年 5 月 25 日的股东支付每股 0.34 美元的季度现金股息。该公司专注于通过创新医疗技术改善各个治疗领域的医疗保健</p>

<p>WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 30, 2026, to shareholders of record at the close of business on May 25, 2026.</p>
<div class="lb-trans"><p>宾夕法尼亚州韦恩 --（商业资讯）-- 泰利福公司（NYSE: TFX）今天宣布，其董事会宣告每股普通股派发季度现金股息三十四美分（$0.34）。该股息将于 2026 年 6 月 30 日支付给截至 2026 年 5 月 25 日营业结束时的股东。</p>
</div><p><strong>About Teleflex Incorporated</strong></p>
<div class="lb-trans"><p><strong>关于泰利福公司</strong></p>
</div><p>As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.</p>
<div class="lb-trans"><p>作为全球医疗技术的提供者，泰利福的使命是改善人们的健康和生活质量。通过我们成为医疗保健最值得信赖的合作伙伴的愿景，我们提供多样化的产品组合，涵盖麻醉、急救医学、介入心脏病学和放射学、外科、血管通路和泌尿学等治疗领域。我们相信，优秀人才的潜力、以使命驱动的创新和世界级产品能够塑造医疗保健的未来方向。</p>
</div><p>Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.</p>
<div class="lb-trans"><p>泰利福是 Arrow™、Barrigel™、Deknatel™、LMA™、Pilling™、QuikClot™ Rüsch™、UroLift™和 Weck™的家园——这些受信赖的品牌因共同的使命而团结在一起。</p>
</div><p>At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.</p>
<div class="lb-trans"><p>在泰利福，我们正在赋能医疗保健的未来。欲了解更多信息，请访问 teleflex.com。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA1MTUxMzg1MDJyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260515138502r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260515138502/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260515138502/en/</p>
</div><p>Teleflex</p>
<div class="lb-trans"><p>泰利福</p>
</div><p>Lawrence Keusch</p>
<div class="lb-trans"><p>劳伦斯·凯施</p>
</div><p>Vice President, Investor Relations and Strategy Development</p>
<div class="lb-trans"><p>投资者关系与战略发展副总裁</p>
</div><p>investor.relations@teleflex.com</p>
<div class="lb-trans"><p>investor.relations@teleflex.com</p>
</div><p>610-948-2836</p>
<div class="lb-trans"><p>610-948-2836</p>
</div><p>Source: Teleflex Incorporated</p>
<div class="lb-trans"><p>来源：泰利福公司</p>
</div>

泰利福宣布季度股息 | TFX 股票资讯